Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients

Table 3 Correlation of initial IV administration with indication and eligibility for oral conversion n (%)

	Appropriate initial IV use	Inappropriate initial IV use	P value
Total IV use (n = 286)	158 (55)	128 (45)
Switched	58 (37)	49 (38)	0.785
Candidate for Switch	82 (52)	127 (99)	< 0.001
Indication
Treatment (35)	22 (14)	13 (10)	0.556
SUP justified (43)	26 (17)	17 (13)	0.556
NSAIDs-induced (justified) (35)	17 (11)	18 (14)	0.556
Other unjustified prophylaxis (173)	93 (59)	80 (63)	0.556
Frequency as once daily	138 (87)	113 (88)	0.81
Dose 40 mg	152 (96)	120 (95)	0.491
Medical floor	68 (47)	78 (53)	0.003
Surgical floor	90 (64)	50 (36)	0.003
Duration of IV use (median ± IQR)	4.0 ± 4.0	4.0 ± 4.0	0.422

IV: Intravenous.